Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study

Abstract Background Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed...

Full description

Bibliographic Details
Main Authors: Yun Lan, Linghua Li, Xiang He, Fengyu Hu, Xizi Deng, Weiping Cai, Junbin Li, Xuemei Ling, Qinghong Fan, Xiaoli Cai, Liya Li, Feng Li, Xiaoping Tang
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Virology Journal
Subjects:
Online Access:https://doi.org/10.1186/s12985-021-01653-6
_version_ 1818728688759341056
author Yun Lan
Linghua Li
Xiang He
Fengyu Hu
Xizi Deng
Weiping Cai
Junbin Li
Xuemei Ling
Qinghong Fan
Xiaoli Cai
Liya Li
Feng Li
Xiaoping Tang
author_facet Yun Lan
Linghua Li
Xiang He
Fengyu Hu
Xizi Deng
Weiping Cai
Junbin Li
Xuemei Ling
Qinghong Fan
Xiaoli Cai
Liya Li
Feng Li
Xiaoping Tang
author_sort Yun Lan
collection DOAJ
description Abstract Background Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comprehensively analyze the prevalence of TDR and the transmission clusters of HIV-1 infected persons before ART in Guangdong. Methods The HIV-1 treatment-naïve patients were recruited between January 2018 and December 2018. The HIV-1 pol region was amplified by reverse transcriptional PCR and sequenced by sanger sequencing. Genotypes, surveillance drug resistance mutations (SDRMs) and TDR were analyzed. Genetic transmission clusters among patients were identified by pairwise Tamura-Nei 93 genetic distance, with a threshold of 0.015. Results A total of 2368 (97.17%) HIV-1 pol sequences were successfully amplified and sequenced from the enrolled 2437 patients. CRF07_BC (35.90%, 850/2368), CRF01_AE (35.56%, 842/2368) and CRF55_01B (10.30%, 244/2368) were the main HIV-1 genotypes circulating in Guangdong. Twenty-one SDRMs were identified among fifty-two drug-resistant sequences. The overall prevalence of TDR was 2.20% (52/2368). Among the 2368 patients who underwent sequencing, 8 (0.34%) had TDR to protease inhibitors (PIs), 22 (0.93%) to nucleoside reverse transcriptase inhibitors (NRTIs), and 23 (0.97%) to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two (0.08%) sequences showed dual-class resistance to both NRTIs and NNRTIs, and no sequences showed triple-class resistance. A total of 1066 (45.02%) sequences were segregated into 194 clusters, ranging from 2 to 414 sequences. In total, 15 (28.85%) of patients with TDR were included in 9 clusters; one cluster contained two TDR sequences with the K103N mutation was observed. Conclusions There is high HIV-1 genetic heterogeneity among patients in Guangdong. Although the overall prevalence of TDR is low, it is still necessary to remain vigilant regarding some important SDRMs.
first_indexed 2024-12-17T22:33:58Z
format Article
id doaj.art-7ca9edfe90d44dcd96caa5230901ddcc
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-12-17T22:33:58Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-7ca9edfe90d44dcd96caa5230901ddcc2022-12-21T21:30:08ZengBMCVirology Journal1743-422X2021-09-011811910.1186/s12985-021-01653-6Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional studyYun Lan0Linghua Li1Xiang He2Fengyu Hu3Xizi Deng4Weiping Cai5Junbin Li6Xuemei Ling7Qinghong Fan8Xiaoli Cai9Liya Li10Feng Li11Xiaoping Tang12Guangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and PreventionGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangdong Center for Diagnosis and Treatment of AIDSGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityGuangzhou Eighth People’s Hospital, Guangzhou Medical UniversityAbstract Background Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comprehensively analyze the prevalence of TDR and the transmission clusters of HIV-1 infected persons before ART in Guangdong. Methods The HIV-1 treatment-naïve patients were recruited between January 2018 and December 2018. The HIV-1 pol region was amplified by reverse transcriptional PCR and sequenced by sanger sequencing. Genotypes, surveillance drug resistance mutations (SDRMs) and TDR were analyzed. Genetic transmission clusters among patients were identified by pairwise Tamura-Nei 93 genetic distance, with a threshold of 0.015. Results A total of 2368 (97.17%) HIV-1 pol sequences were successfully amplified and sequenced from the enrolled 2437 patients. CRF07_BC (35.90%, 850/2368), CRF01_AE (35.56%, 842/2368) and CRF55_01B (10.30%, 244/2368) were the main HIV-1 genotypes circulating in Guangdong. Twenty-one SDRMs were identified among fifty-two drug-resistant sequences. The overall prevalence of TDR was 2.20% (52/2368). Among the 2368 patients who underwent sequencing, 8 (0.34%) had TDR to protease inhibitors (PIs), 22 (0.93%) to nucleoside reverse transcriptase inhibitors (NRTIs), and 23 (0.97%) to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two (0.08%) sequences showed dual-class resistance to both NRTIs and NNRTIs, and no sequences showed triple-class resistance. A total of 1066 (45.02%) sequences were segregated into 194 clusters, ranging from 2 to 414 sequences. In total, 15 (28.85%) of patients with TDR were included in 9 clusters; one cluster contained two TDR sequences with the K103N mutation was observed. Conclusions There is high HIV-1 genetic heterogeneity among patients in Guangdong. Although the overall prevalence of TDR is low, it is still necessary to remain vigilant regarding some important SDRMs.https://doi.org/10.1186/s12985-021-01653-6HIV-1Transmitted drug resistanceTransmission clusterGuangdong
spellingShingle Yun Lan
Linghua Li
Xiang He
Fengyu Hu
Xizi Deng
Weiping Cai
Junbin Li
Xuemei Ling
Qinghong Fan
Xiaoli Cai
Liya Li
Feng Li
Xiaoping Tang
Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
Virology Journal
HIV-1
Transmitted drug resistance
Transmission cluster
Guangdong
title Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_full Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_fullStr Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_full_unstemmed Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_short Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_sort transmitted drug resistance and transmission clusters among hiv 1 treatment naive patients in guangdong china a cross sectional study
topic HIV-1
Transmitted drug resistance
Transmission cluster
Guangdong
url https://doi.org/10.1186/s12985-021-01653-6
work_keys_str_mv AT yunlan transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT linghuali transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT xianghe transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT fengyuhu transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT xizideng transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT weipingcai transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT junbinli transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT xuemeiling transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT qinghongfan transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT xiaolicai transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT liyali transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT fengli transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT xiaopingtang transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy